Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Drug metformin and lifestyle changes can help treat weight gain induced by antipsychotic drugs

Lifestyle intervention and the drug metformin are both effective against antipsychotic-induced weight gain, and treatment is most effective when the two therapies are combined, according to a study in the January 9/16 issue of JAMA.

9 Jan 2008

Carrot cake study on sugar in type 2 diabetes

Patients with type 2 diabetes are often advised to cut out sucrose (table sugar) all together.

9 Jan 2008

Takeda submits NDA for Alogliptin (SYR-322) in the U.S.

Takeda Pharmaceutical Company Limited (Takeda) has announced that Takeda Global Research & Development Center, Inc. submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for alogliptin (development code: SYR-322), a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes.

7 Jan 2008

The benefits of 30 minutes of exercise

What's the key to looking and feeling better and enhancing your health Exercise.

3 Jan 2008

Testosterone supplementation in older men

Older men with low testosterone levels who received testosterone supplementation increased lean body mass and decreased body fat, but were no stronger and had no improvement in mobility or cognition compared with men who did not use the supplement, according to a study in the January 2 issue of JAMA.

2 Jan 2008

Deep sleep maintains normal glucose control

Suppression of slow-wave sleep in healthy young adults significantly decreases their ability to regulate blood-sugar levels and increases the risk of type 2 diabetes, report researchers at the University of Chicago Medical Center in the "Early Edition" of the Proceedings of the National Academy of Science, available online as soon as Dec. 31, 2007.

2 Jan 2008

New clinical practice recommendations to help health care providers treat people with diabetes

The American Diabetes Association (ADA) has issued its annual Clinical Practice Recommendations to help health care providers treat people with diabetes using the most current evidence available.

2 Jan 2008

Two genes are important key to regulating immune response

A research team at Weill Cornell Medical College in New York City has identified two genes that may be crucial to the production of an immune system cytokine called interleukin-10 (IL-10)

2 Jan 2008

Children short of sleep three times as likely to be obese

According to new research by scientists in New Zealand children who do not get enough sleep face an increased risk of obesity and behavioral problems.

2 Jan 2008

Diabetes linked to poor sleep quality

According to new research from the U.S. having a good night's sleep has important health ramifications.

2 Jan 2008

Rituximab may be promising treatment for diabetes

An antibody used to treat certain cancers and rheumatoid arthritis appears to greatly delay type 1 diabetes in mice, Yale School of Medicine researchers report in the Journal of Clinical Investigation.

20 Dec 2007

Oral diabetes medication - new guidelines

A pair of plain-language guides that outline the latest scientific evidence on the effectiveness and safety of oral medications for adults with type 2 diabetes are now available from HHS' Agency for Healthcare Research and Quality.

18 Dec 2007

Medical College of Georgia selected as RNA laboratory for worldwide diabetes study

The Medical College of Georgia Center for Biotechnology and Genomic Medicine has been selected to isolate RNA and DNA from the blood of thousands of children involved in a worldwide study of the causes of type 1 diabetes.

18 Dec 2007

Discovery reveals how fat is stored in cells

In discovering the genes responsible for storing fat in cells, scientists at the Albert Einstein College of Medicine of Yeshiva University have answered one of biology's most fundamental questions.

18 Dec 2007

Use of thiazolidinediones by seniors linked with increased risk of heart problems

Older patients treated with the diabetes medications known as thiazolidinediones (which include rosiglitazone) had a significantly increased risk of heart attack, congestive heart failure and death, compared with the use of other hypoglycemic drugs, according to a study in the December 12 issue of JAMA.

13 Dec 2007

Fructose overload

Here's one tip for how to eat at the holidays: Don't take your cues from Santa. The sugary cookies and fat-laden fruitcakes the mythical North Pole resident eats are a no-no.

13 Dec 2007

Smoking and type 2 diabetes

A review of previous studies indicates that people who currently smoke have an increased risk of developing type 2 diabetes, compared with non-smokers, according to an article in the December 12 issue of JAMA.

13 Dec 2007

$1.7 million grant to advance understanding of genetic influences on diabetes

Scientists at Southwest Foundation for Biomedical Research (SFBR) expect to make big leaps in their understanding of genetic influences on diabetes, thanks to a new $1.7 million grant awarded to Dr. Joanne Curran, the grant's principal investigator.

13 Dec 2007

Anti-diabetic drug pioglitazone lowers cardiovascular risk in diabetic patients with kidney disease

A new study confirms that chronic kidney disease (CKD) increases the already-high risk of serious cardiovascular events in diabetic patients with damage to the large blood vessels and suggests that treatment with the anti-diabetic drug pioglitazone may help to lower this risk, reports the January Journal of the American Society of Nephrology.

13 Dec 2007

Study finds Avandia may increase risk of heart failure

A popular class of drugs for treating type 2 diabetes is under scrutiny again. A new Canadian study released by the Institute for Clinical Evaluative Sciences (ICES) finds that drugs such as Avandia increase the risk of heart failure, heart attacks and death.

13 Dec 2007